YUNNAN BAIYAO(SZ:000538)2024-06-03 09:52Financial Performance - In Q1 2024, the company achieved a revenue of 10.774 billion CNY, a year-on-year increase of 2.49% [2] - The net profit attributable to shareholders was 1.702 billion CNY, up 12.12% year-on-year [2] - The basic earnings per share reached 0.95 CNY, reflecting an 11.76% increase [2] - The weighted average return on equity was 4.18%, an increase of 0.31 percentage points year-on-year [2] Core Product Sales - The core product series maintained a strong growth trend in 2023, with a gross margin of 70.6% [3] - Sales revenue from Yunnan Baiyao aerosol exceeded 1.7 billion CNY, growing by 15.27% year-on-year [3] - Other products, including Yunnan Baiyao adhesive bandages and ointments, also reported significant sales, with revenues over 900 million CNY and 600 million CNY respectively [3] Herbal Material Pricing Impact - The Chinese herbal resources division generated 1.71 billion CNY in external revenue, a year-on-year increase of approximately 22% [4] - The external sales of the herb Sanqi saw a substantial growth of 81% [4] - Despite a general increase in herbal material prices, the company's input material price increase was significantly lower than the industry average, which rose by 17.3% [4] Dividend Distribution - In 2023, the dividend plan was set at 20.77 CNY per 10 shares, totaling 3.706 billion CNY, which accounted for 90.53% of the net profit attributable to shareholders [5] - The company has consistently paid dividends for 31 years since its listing, with cumulative cash dividends exceeding 24.4 billion CNY [5]